IP Library Granted Patent US 9,533,011
Granted Patent B2
US 9,533,011 · App. 14/171,511 · Granted Jan 3, 2017

Placental tissue grafts and methods of preparing and using the same

Inventors: John Daniel (Woodstock, GA); Randall Spencer (Acworth, GA); John Russo (Sarasota, FL); Robert Tofe (Denver, CO)
Assignee: MiMedx Group, Inc.
A61K35/28A61F2/02A61K9/7007A61K35/19A61K35/33A61K35/50A61L27/3604A61L27/3683A61L27/3834A61L27/56A61F2210/00A61F2230/00A61L2430/34A61L2430/40Y10T156/10Y10T156/1039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,533,011
App. No.
14/171,511
Granted
Jan 3, 2017
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims (12)

1. A method for preparing a de-epithelialized multilayer laminate comprising at least one amnion layer which method comprises:

placing at least one modified amnion layer comprising a first side which is an exposed basement membrane and a second side which retains a fibroblast cellular layer in contact with a second layer such that the amnion layer is positioned to contact its fibroblast cellular layer with the second layer;

optionally adding one or more additional layers to said amnion or to said second layer; and

dehydrating and laminating the layers under heated conditions;

wherein the second layer is selected from the group consisting of amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, a biocellulose polymer or copolymers, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, and a combination thereof.

2. The method of claim 1 , wherein the second layer is amnion or chorion.

3. The method of claim 1 , wherein the dehydrating and laminating are conducted in a drying fixture.

4. The method of claim 3 , wherein the surface of the drying fixture has a plurality of grooves that defines the outer contours of each of the plurality of placenta.

5. The method of claim 3 , wherein the drying fixture includes a texture or design adapted to emboss such texture or design into the basement membrane during dehydration.

6. The method of claim 1 , wherein the heated conditions comprise a temperature of between 35° C. and 50° C. and a period of between 30 and 120 minutes.

7. The method of claim 1 , wherein the one or more additional layers comprises amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, or any combination thereof.

8. The method of claim 1 , wherein the one or more additional layers comprises chorion, amnion, or a combination thereof.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2015
From: DANIEL, JOHN; TOFE, ROBERT; SPENCER, RANDALL; RUSSO, JOHN
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 037029/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2015
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 037029/0011 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 033932/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 033932/0600 →
Continuity (9)
Continuation 13861305 · Apr 11, 2013
Continuation 13765640 · Feb 12, 2013
Continuation 13569134 · Aug 7, 2012
Continuation 12428908 · Apr 23, 2009
Continuation 12206508 · Sep 8, 2008
Provisional Application 60970780 · Sep 7, 2007
Provisional Application 60986665 · Nov 9, 2007
Provisional Application 60989299 · Nov 20, 2007
Related Publication 20140290837A1 · Oct 2, 2014